News
01-10-2013, 02:20 AM
Less than 10 years and risks are likely to outweigh benefits Breast and colorectal cancer screening should be targeted towards patients with a life expectancy greater than 10 years: for any shorter life expectancy the harms are likely to outweigh the benefits, concludes a study published on bmj.com today...
More... (http://www.medicalnewstoday.com/releases/254741.php)
More... (http://www.medicalnewstoday.com/releases/254741.php)